ProStrakan Secures Offer From Japan's Kyowa Hakko, But Analysts Say Too Low
This article was originally published in The Pink Sheet Daily
Executive Summary
Kyowa Hakko Kirin's offer to buy U.K.-based specialty pharma ProStrakan values the company lower than other similar deals.